Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
1 result
Topics : Diseases and conditions
Topics : Skin and connective tissue diseases
Topics : Skin and connective tissue cancers
Topics : Digestive system diseases
Topics : Respiratory tract diseases
Topics : Respiratory tract cancers
Topics : Diagnostic and therapeutic techniques
Topics : Radiotherapy and physical agents
Language : Français
OK
Chercher
Filter
Topic
Diagnostic and therapeutic techniques
(1)
Plus ...
Drug therapy
(1)
Radiotherapy and physical agents
(1)
Diseases and conditions
(1)
Plus ...
Respiratory tract diseases
(1)
Plus ...
Respiratory tract cancers
(1)
Digestive system diseases
(1)
Plus ...
Digestive system cancers
(1)
Skin and connective tissue diseases
(1)
Plus ...
Skin and connective tissue cancers
(1)
Content type
Drugs, devices and medical acts
(1)
Plus ...
Medicine
(1)
Language
Français
(1)
More filter
Save your search
Drugs, devices and medical acts
- 1 result
ERBITUX (cetuximab)
Medicine
- Posted on 8/1/2016 - Mis à jour le 12/6/2019
Add to
my selection
Français
English
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
JxemsG5BQRr9S3mv